Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05470920 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.
MinorTrial completedFinal enrollment: 297 participants (planned 350) · Primary completion date changed from estimate of Sep 30, 2026 to May 19, 2026 · Eligibility criteria expanded, about 7 words · 3 moreShow 6 more changesShow less
Final enrollment: 297 participants (planned 350)
Primary completion date changed from estimate of Sep 30, 2026 to May 19, 2026
Eligibility criteria expanded, about 7 words
Secondary endpoints: details revised at 1 of 4 entries
Site details revised at 2 of 2 sites
Study description expanded, about 3 words
NotablePrimary completion date: Oct 31, 2025 to Sep 30, 2026Completion date: Oct 31, 2025 to Dec 31, 2026 · Site contacts updated at 1 of 2 sitesv5Show 2 more changesShow less
Completion date: Oct 31, 2025 to Dec 31, 2026
Site contacts updated at 1 of 2 sites
MinorRe-verified, no change to tracked fieldsv4
MinorStart date changed from estimate of Jan 2023 to Oct 14, 2022v3
NotableTrial status: Not Yet Recruiting to RecruitingSite details revised at 2 of 2 sitesv2Show 1 more changeShow less
Site details revised at 2 of 2 sites
MinorStudy First Submitted
Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a randomized trial to evaluate the effectiveness of an electronic decision aid tool versus a traditional genetic counselor session for multi-gene panel testing for people with ovarian or pancreatic cancer